Loading…

Efficacy of Pre-Hospital Use of Glycoprotein IIb/IIIa Inhibitors in ST-Segment Elevation Myocardial Infarction Before Mechanical Reperfusion in a Rapid-Transfer Network (from the Acute Myocardial Infarction Registry of Brittany)

Previous studies investigating prehospital use of glycoprotein IIb/IIIa inhibitors (GPIs) in patients with ST-segment elevation myocardial infarction reached conflicting conclusions. The benefit of this strategy in addition to in-ambulance loading of dual-antiplatelet therapy remains controversial....

Full description

Saved in:
Bibliographic Details
Published in:The American journal of cardiology 2014-07, Vol.114 (2), p.214-223
Main Authors: Auffret, Vincent, MD, Oger, Emmanuel, MD PhD, Leurent, Guillaume, MD, Filippi, Emmanuelle, MD, Coudert, Isabelle, MD, Hacot, Jean Philippe, MD, Castellant, Philippe, MD, Rialan, Antoine, MD, Delaunay, Régis, MD, Rouault, Gilles, MD, Druelles, Philippe, MD, Boulanger, Bertrand, MD, Treuil, Josiane, MD, Avez, Bertrand, MD, Bedossa, Marc, MD, Boulmier, Dominique, MD, Le Guellec, Marielle, MSc, Le Breton, Hervé, MD, PhD
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Previous studies investigating prehospital use of glycoprotein IIb/IIIa inhibitors (GPIs) in patients with ST-segment elevation myocardial infarction reached conflicting conclusions. The benefit of this strategy in addition to in-ambulance loading of dual-antiplatelet therapy remains controversial. The aim of this study was to analyze data from a prospective registry of patients with ST-segment elevation myocardial infarctions admitted
ISSN:0002-9149
1879-1913
DOI:10.1016/j.amjcard.2014.04.029